Shopping Cart
Remove All
Your shopping cart is currently empty
JD-02 is a novel Hsp90 inhibitor that can induce autophagy and apoptosis in cells. Additionally, JD-02 elevates levels of reactive oxygen species (ROS).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | JD-02 is a novel Hsp90 inhibitor that can induce autophagy and apoptosis in cells. Additionally, JD-02 elevates levels of reactive oxygen species (ROS). |
| In vitro | JD-02 inhibits the growth of HTC116 and SW620 cells at concentrations of 0–2 μM over 24, 48, and 72 hours. Additionally, JD-02 at 1 μM for 36 to 72 hours induces G0/G1 phase arrest in these cells. Furthermore, JD-02 at 1 μM for 48 hours triggers apoptosis in HTC116 and SW620 cells. |
| In vivo | JD-02 (5, 10, and 20 mg/kg; intraperitoneal injection; 21 days) was effective in reducing tumor growth in the HCT116 cell xenograft mouse model.Animal Model: HCT116 cell xenograft mouse model Dosage: 5, 10, and 20 mg/kg Administration: Intravenous injection for 21 days Result: reduced tumor growth by 64.3%. |
| Formula | C23H32N6O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.